Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma

Haitham Hilal Al Mahrouqi, Anuradha Ganesh, Abdulhakim Al Rawas, Vikas Khetan, Sana Al Zuhaibi

نتاج البحث: المساهمة في مجلةمراجعة النظراء

1 اقتباس (Scopus)

ملخص

A 3-year-old child was incidentally found to have chronic myelogenous leukemia (CML) during an admission for a routine ophthalmic examination under anesthesia. The child had received systemic chemotherapy and focal treatment for Groups C and D retinoblastoma in the right and left eye, respectively, when she was 7 months old. CML was treated with dasatinib, and the child attained a major molecular response. The child is now 3 years after treatment of CML, and the retinoblastoma remains inactive. CML following treatment of retinoblastoma is a rare occurrence. Long term and close monitoring of retinoblastoma patients who received systemic chemotherapy using serial blood tests is essential.

اللغة الأصليةEnglish
الصفحات (من إلى)187-189
عدد الصفحات3
دوريةOman Journal of Ophthalmology
مستوى الصوت14
رقم الإصدار3
المعرِّفات الرقمية للأشياء
حالة النشرPublished - سبتمبر 1 2021
منشور خارجيًانعم

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2731???

بصمة

أدرس بدقة موضوعات البحث “Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا